Tag Archives: intrexon

April, 2017

January, 2017

  • 25 January

    Intrexon to Acquire GenVec for Gene Delivery Technology

    GERMANTOWN, Md., and GAITHERSBURG, Md., Jan. 24, 2017 /PRNewswire/ — Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that it has entered into a definitive agreement to acquire GenVec, Inc. (NASDAQ: GNVC), a …

March, 2015

  • 30 March

    Merck Serono and Intrexon Strike CAR-T Therapy Collaboration

    Merck Serono is partnering with Intrexon Corporation to develop Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. The companies announced today that they have entered an exclusive strategic collaboration and license agreement for CAR-T cancer drugs, advancing Merck Serono’s comprehensive, science-driven strategy to develop innovative therapies that modulate the immune system’s …

February, 2015

January, 2015

  • 26 January

    Intrexon to Buy Remaining Stake in Exemplar Genetics

    Today, Intrexon Corporation announced that it has launched a tender offer to acquire the remaining stake in Exemplar Genetics, which it did not acquire through its purchase of Trans Ova Genetics. Exemplar is focused on enabling the study of life-threatening human diseases. By using its proprietary technologies in animal genetics, …

  • 14 January

    Intrexon and Ziopharm Oncology Enter CAR-T License Deal with MD Anderson

    Intrexon Corporation and its oncology partner Ziopharm Oncology have entered an immunotherapy deal with MD Anderson Cancer Center. The companies announced that they have entered into a broad exclusive licensing agreement with the cancer center, including an exclusive sublicensing agreement through MD Anderson for intellectually property developed at the University …